Stay updated on Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” in accordance with Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T15:37:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T22:21:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:12:31.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the usual study record content with a basic error layout that includes a 403 header and a Home link. Access to the requested record appears restricted.
    Difference
    20%
    Check dated 2026-09-20T22:30:18.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added a new site revision tag: Revision: v3.6.6. Deleted older taxonomy items, including 'Breast cancer' and 'MedlinePlus Genetics', and removed the prior revision tag 'Revision: v3.6.5'.
    Difference
    0.2%
    Check dated 2026-08-30T21:57:08.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.6.5 appears on the page, replacing the previous v3.6.4. This indicates a site update with no changes to study data or page content.
    Difference
    0.0%
    Check dated 2026-08-09T12:23:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.